633 related articles for article (PubMed ID: 31500099)
1. An Overview of Circular RNAs and Their Implications in Myotonic Dystrophy.
Czubak K; Sedehizadeh S; Kozlowski P; Wojciechowska M
Int J Mol Sci; 2019 Sep; 20(18):. PubMed ID: 31500099
[TBL] [Abstract][Full Text] [Related]
2. Dysregulation of Circular RNAs in Myotonic Dystrophy Type 1.
Voellenkle C; Perfetti A; Carrara M; Fuschi P; Renna LV; Longo M; Sain SB; Cardani R; Valaperta R; Silvestri G; Legnini I; Bozzoni I; Furling D; Gaetano C; Falcone G; Meola G; Martelli F
Int J Mol Sci; 2019 Apr; 20(8):. PubMed ID: 31010208
[TBL] [Abstract][Full Text] [Related]
3. The emerging landscape of circular RNA in cardiovascular diseases.
Zhou MY; Yang JM; Xiong XD
J Mol Cell Cardiol; 2018 Sep; 122():134-139. PubMed ID: 30118789
[TBL] [Abstract][Full Text] [Related]
4. Insights into the biogenesis and potential functions of exonic circular RNA.
Ragan C; Goodall GJ; Shirokikh NE; Preiss T
Sci Rep; 2019 Feb; 9(1):2048. PubMed ID: 30765711
[TBL] [Abstract][Full Text] [Related]
5. Analysis of MTMR1 expression and correlation with muscle pathological features in juvenile/adult onset myotonic dystrophy type 1 (DM1) and in myotonic dystrophy type 2 (DM2).
Santoro M; Modoni A; Masciullo M; Gidaro T; Broccolini A; Ricci E; Tonali PA; Silvestri G
Exp Mol Pathol; 2010 Oct; 89(2):158-68. PubMed ID: 20685272
[TBL] [Abstract][Full Text] [Related]
6. Aberrantly spliced alpha-dystrobrevin alters alpha-syntrophin binding in myotonic dystrophy type 1.
Nakamori M; Kimura T; Kubota T; Matsumura T; Sumi H; Fujimura H; Takahashi MP; Sakoda S
Neurology; 2008 Feb; 70(9):677-85. PubMed ID: 18299519
[TBL] [Abstract][Full Text] [Related]
7. Alternative splicing regulation by Muscleblind proteins: from development to disease.
Fernandez-Costa JM; Llamusi MB; Garcia-Lopez A; Artero R
Biol Rev Camb Philos Soc; 2011 Nov; 86(4):947-58. PubMed ID: 21489124
[TBL] [Abstract][Full Text] [Related]
8. Alternative splicing of myomesin 1 gene is aberrantly regulated in myotonic dystrophy type 1.
Koebis M; Ohsawa N; Kino Y; Sasagawa N; Nishino I; Ishiura S
Genes Cells; 2011 Sep; 16(9):961-72. PubMed ID: 21794030
[TBL] [Abstract][Full Text] [Related]
9. Comprehensive identification of alternative back-splicing in human tissue transcriptomes.
Zhang P; Zhang XO; Jiang T; Cai L; Huang X; Liu Q; Li D; Lu A; Liu Y; Xue W; Zhang P; Weng Z
Nucleic Acids Res; 2020 Feb; 48(4):1779-1789. PubMed ID: 31974555
[TBL] [Abstract][Full Text] [Related]
10. Gain of RNA function in pathological cases: Focus on myotonic dystrophy.
Klein AF; Gasnier E; Furling D
Biochimie; 2011 Nov; 93(11):2006-12. PubMed ID: 21763392
[TBL] [Abstract][Full Text] [Related]
11. Molecular mechanisms responsible for aberrant splicing of SERCA1 in myotonic dystrophy type 1.
Hino S; Kondo S; Sekiya H; Saito A; Kanemoto S; Murakami T; Chihara K; Aoki Y; Nakamori M; Takahashi MP; Imaizumi K
Hum Mol Genet; 2007 Dec; 16(23):2834-43. PubMed ID: 17728322
[TBL] [Abstract][Full Text] [Related]
12. Global Increase in Circular RNA Levels in Myotonic Dystrophy.
Czubak K; Taylor K; Piasecka A; Sobczak K; Kozlowska K; Philips A; Sedehizadeh S; Brook JD; Wojciechowska M; Kozlowski P
Front Genet; 2019; 10():649. PubMed ID: 31428124
[TBL] [Abstract][Full Text] [Related]
13. The expanding regulatory mechanisms and cellular functions of circular RNAs.
Chen LL
Nat Rev Mol Cell Biol; 2020 Aug; 21(8):475-490. PubMed ID: 32366901
[TBL] [Abstract][Full Text] [Related]
14. Circular RNAs in Muscle Function and Disease.
Greco S; Cardinali B; Falcone G; Martelli F
Int J Mol Sci; 2018 Nov; 19(11):. PubMed ID: 30400273
[TBL] [Abstract][Full Text] [Related]
15. Brain-specific change in alternative splicing of Tau exon 6 in myotonic dystrophy type 1.
Leroy O; Wang J; Maurage CA; Parent M; Cooper T; Buée L; Sergeant N; Andreadis A; Caillet-Boudin ML
Biochim Biophys Acta; 2006 Apr; 1762(4):460-7. PubMed ID: 16487687
[TBL] [Abstract][Full Text] [Related]
16. Loss of the muscle-specific chloride channel in type 1 myotonic dystrophy due to misregulated alternative splicing.
Charlet-B N; Savkur RS; Singh G; Philips AV; Grice EA; Cooper TA
Mol Cell; 2002 Jul; 10(1):45-53. PubMed ID: 12150906
[TBL] [Abstract][Full Text] [Related]
17. Role of Circular RNAs in Cardiovascular Disease.
Kishore R; Garikipati VNS; Gonzalez C
J Cardiovasc Pharmacol; 2020 Aug; 76(2):128-137. PubMed ID: 32398477
[TBL] [Abstract][Full Text] [Related]
18. RNA-binding protein Muscleblind-like 3 (MBNL3) disrupts myocyte enhancer factor 2 (Mef2) {beta}-exon splicing.
Lee KS; Cao Y; Witwicka HE; Tom S; Tapscott SJ; Wang EH
J Biol Chem; 2010 Oct; 285(44):33779-87. PubMed ID: 20709755
[TBL] [Abstract][Full Text] [Related]
19. Expression of MBNL and CELF mRNA transcripts in muscles with myotonic dystrophy.
Nezu Y; Kino Y; Sasagawa N; Nishino I; Ishiura S
Neuromuscul Disord; 2007 Apr; 17(4):306-12. PubMed ID: 17331722
[TBL] [Abstract][Full Text] [Related]
20. The roles of circRNAs in cancers: Perspectives from molecular functions.
Cao YZ; Sun JY; Chen YX; Wen CC; Wei L
Gene; 2021 Jan; 767():145182. PubMed ID: 32991954
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
